Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.06T, Eli Lilly(LLY) trades at $1,122.60. The stock has a price-to-earnings ratio of 40.78 and currently yields dividends of 0.57%.
On 2026-06-16, Eli Lilly(LLY) stock moved within a range of $1,115.50 to $1,146.68. With shares now at $1,122.60, the stock is trading +0.6% above its intraday low and -2.1% below the session's peak.
Trading activity shows a volume of 2.26M, compared to an average daily volume of 3.25M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.
LLY News
Eli Lilly (LLY) is expanding into the market for non-addictive painkillers with its latest acquisition. Unlock powerful investing tools and data-driven insight...
...
Key Points Eli Lilly currently leads the weight loss market. Novo Nordisk's newer launches could help it make up some ground. Both could capitalize on the gr...
Analyst ratings
84%
of 32 ratingsMore LLY News
Biotech and Pharma Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work. In this article LLY Eli Lilly acquired Austin-based 4E T...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium...
4E Therapeutics, an Austin-based neuroscience company developing treatments for chronic pain, announced that it has been acquired by Eli Lilly (LLY). 4E says it...
Novo Nordisk (NVO) is stepping up its competition with rival Eli Lilly (LLY) in China’s oral weight loss drug market. According to a Reuters report, CEO Mike Do...
Eli Lilly (NYSE:LLY) reported that its non-covalent BTK inhibitor Jaypirca reduced the risk of disease progression or death by 45% in the Phase 3 BRUIN CLL-322...
The study found that adding Jaypirca to a time-limited two-year regimen of venetoclax and rituximab reduced the risk of disease progression or death by 45% comp...
Eli Lilly (LLY 0.29%) is back up to $1 trillion in market cap. This year, the stock is up a modest 5%, but over five years, its returns are incredibly impressiv...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.